As a T cell specificity control, an insulin-specific CD4 TCR transductant (5KC-clone 5) that responds to insulin B chain amino acids 13-23 presented by the T1D risk HLA class II molecule, HLA-DQ8, was used in these experiments (30). The gene discussed is CD4; the disease is type 1 diabetes mellitus.